Novartis Investigative Site

Ibague, Tolima Department 730006

0 studies enrolling now · 6 studies all time

What they study most

Ankylosing Spondylitis, Asthma, Autoimmunity, Inflammation, Breast Cancer, Primary Prevention of Atherosclerotic Cardiovascular Disease

Studies at this site

• Secukinumab Open Label Roll-over Extension Protocol — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma — Completed
• Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer — Completed
• Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA — Completed
• Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment — Stopped early